Agios Pharmaceuticals, Inc.
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.13 | 0.13 | 0.15 | 0.15 | 0.15 | 0.19 | 0.15 | 0.21 | 0.22 | 0.34 | 0.35 | 0.75 | 1.65 | |
| 0.01 | 0.04 | 0.04 | 0.05 | 0.01 | 0.02 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.20 | |
| 0.12 | 0.09 | 0.11 | 0.10 | 0.14 | 0.17 | 0.11 | 0.16 | 0.17 | 0.29 | 0.31 | 0.70 | 1.45 | |
| 1.47 | 1.36 | 1.19 | 1.33 | 1.24 | 1.45 | 1.24 | 1.57 | 1.47 | 1.49 | 1.36 | 1.69 | 5.93 | |
| 0.46 | 0.63 | 0.55 | 0.63 | 0.66 | 0.90 | 0.72 | 0.79 | 0.71 | 0.88 | 0.82 | 0.87 | 3.24 | |
| 1.93 | 1.99 | 1.74 | 1.96 | 1.90 | 2.35 | 1.97 | 2.36 | 2.18 | 2.37 | 2.18 | 2.56 | 9.17 | |
| -1.81 | -1.90 | -1.63 | -1.86 | -1.76 | -2.19 | -1.86 | -2.19 | -2.01 | -2.08 | -1.87 | -1.86 | -7.72 | |
| -1.64 | -1.72 | -1.45 | -1.69 | 17.13 | -1.84 | -1.55 | -1.93 | -1.78 | -1.87 | -1.69 | -1.69 | -6.93 | |
| -0.18 | 0.02 | 0.02 | – | 0.91 | -0.16 | – | – | – | -0.02 | – | – | – | |
| -1.64 | -1.72 | -1.45 | -1.69 | 16.22 | -1.69 | -1.55 | -1.93 | -1.78 | -1.85 | -1.69 | -1.69 | -6.91 | |
| -1.61 | -1.69 | -1.42 | -1.66 | 17.15 | -1.82 | -1.53 | -1.91 | -1.76 | -1.85 | -1.66 | -1.84 | -7.01 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.